|
rs1001179
CAT
Catalase promoter variant affecting hydrogen peroxide clearance and antioxidants defense capacity
|
CAT
|
Biological Aging & Telomeres
|
—
|
|
rs10455872
LPA
Intronic variant strongly associated with elevated lipoprotein(a) levels and significantly increased risk of coronary artery disease and aortic valve stenosis
|
LPA
|
Heart & Cardiovascular
|
—
|
|
rs1042522
TP53
p53 codon 72 polymorphism producing two functionally distinct proteins — Arg72 with stronger apoptotic activity, Pro72 favoring cell cycle arrest and DNA repair — with population data associating Pro/Pro with ~3 years longer median lifespan
|
TP53
|
Biological Aging & Telomeres
|
—
|
|
rs11591147
PCSK9
Loss-of-function variant that naturally lowers LDL cholesterol by 15-28% and reduces coronary disease risk by up to 47%
|
PCSK9
|
Heart & Cardiovascular
|
—
|
|
rs10830963
MTNR1B
Melatonin receptor variant that extends nighttime melatonin signaling in pancreatic beta cells, impairing glucose-stimulated insulin secretion — especially when meals are eaten late
|
MTNR1B
|
Hormones & Circadian Rhythm
|
—
|
|
rs11206244
DIO1
Common variant in the 3' UTR of the DIO1 gene affecting thyroid hormone metabolism and T3/T4 ratio
|
DIO1
|
Hormones & Circadian Rhythm
|
—
|
|
rs1050450
GPX1
Selenium-dependent antioxidant enzyme that neutralizes hydrogen peroxide; the Leu variant reduces enzyme activity and responsiveness to selenium
|
GPX1
|
Biological Aging & Telomeres
|
—
|
|
rs11209026
IL23R
Strongly protective variant against inflammatory bowel disease and other autoimmune conditions through impaired IL-23 signaling
|
IL23R
|
Inflammation & Immune Aging
|
—
|
|
rs11555236
SIRT3
Intronic regulatory variant near the SIRT3 VNTR enhancer — the A allele increases SIRT3 expression and is linked to longevity in women
|
SIRT3
|
Biological Aging & Telomeres
|
—
|
|
rs1800562
HFE
Primary variant causing hereditary hemochromatosis type 1, disrupting iron regulation and hepcidin signaling
|
HFE
|
Metabolism & Blood Sugar
|
—
|
|
rs1800629
TNF
Promoter variant increasing TNF-alpha production approximately 2-fold, associated with autoimmune diseases and anti-TNF drug response
|
TNF
|
Inflammation & Immune Aging
|
—
|
|
rs1205
CRP
3' UTR variant that modulates baseline C-reactive protein levels and inflammatory status
|
CRP
|
Inflammation & Immune Aging
|
—
|
|
rs1333049
CDKN2B-AS1
Strongest GWAS signal for coronary artery disease; risk C allele accelerates vascular senescence by dysregulating ANRIL-mediated repression of the p16/p15 cell-cycle-inhibitor cluster at 9p21.3
|
CDKN2B-AS1
|
Heart & Cardiovascular
|
—
|
|
rs12696304
TERC
Regulatory variant near the telomerase RNA gene associated with shorter telomeres and accelerated cellular aging
|
TERC
|
Biological Aging & Telomeres
|
—
|
|
rs11136000
CLU
Intronic variant in clusterin gene affecting Alzheimer's disease risk through regulation of amyloid-beta clearance
|
CLU
|
Brain & Cognition
|
—
|
|
rs1501299
ADIPOQ
Intronic variant in the adiponectin gene that influences circulating adiponectin levels, insulin sensitivity, and metabolic response to diet; the T allele is associated with lower adiponectin and higher insulin resistance
|
ADIPOQ
|
Metabolism & Blood Sugar
|
—
|
|
rs17782313
MC4R
Intergenic variant 188kb downstream of MC4R affecting appetite regulation, meal size, and obesity risk
|
MC4R
|
Metabolism & Blood Sugar
|
—
|
|
rs143383
GDF5
Regulatory variant in GDF5 affecting cartilage development and osteoarthritis risk in knees, hips, and spine
|
GDF5
|
Skeletal & Joints
|
—
|
|
rs16944
IL1B
Promoter variant affecting IL-1 beta production, influencing inflammatory response and cardiovascular disease risk
|
IL1B
|
Inflammation & Immune Aging
|
—
|
|
rs174547
FADS1
Omega-3 fatty acid conversion efficiency - affects ability to make EPA/DHA from plant sources
|
FADS1
|
Metabolism & Blood Sugar
|
—
|
|
rs58542926
TM6SF2
Lipid transport variant that impairs VLDL secretion, creating a paradoxical trade-off between liver and heart health
|
TM6SF2
|
Metabolism & Blood Sugar
|
—
|
|
rs231775
CTLA4
Missense variant in the CTLA-4 leader peptide that reduces surface expression of this immune checkpoint receptor, increasing T cell activity and autoimmune disease risk
|
CTLA4
|
Inflammation & Immune Aging
|
—
|
|
rs1800012
COL1A1
Sp1 transcription factor binding site polymorphism affecting collagen production, bone mineral density, and osteoporotic fracture risk
|
COL1A1
|
Skeletal & Joints
|
—
|
|
rs1800775
CETP
CETP promoter variant that reduces CETP expression via Sp1/Sp3 repression, raising HDL cholesterol by ~3–6 mg/dL in A allele carriers
|
CETP
|
Heart & Cardiovascular
|
—
|
|
rs1800872
IL10
Promoter variant affecting IL-10 production — a key anti-inflammatory cytokine regulating inflammation and cardiovascular risk
|
IL10
|
Inflammation & Immune Aging
|
—
|
|
rs2476601
PTPN22
The strongest non-HLA autoimmune risk allele, affecting T-cell and B-cell signaling threshold
|
PTPN22
|
Inflammation & Immune Aging
|
—
|
|
rs1799941
SHBG
Promoter region variant affecting sex hormone-binding globulin levels, with the A allele increasing SHBG by 15-25% and influencing free testosterone and estradiol bioavailability
|
SHBG
|
Hormones & Circadian Rhythm
|
—
|
|
rs738409
PNPLA3
Strongest genetic risk factor for non-alcoholic fatty liver disease, progression to cirrhosis, and hepatocellular carcinoma
|
PNPLA3
|
Metabolism & Blood Sugar
|
—
|
|
rs1800795
IL6
Promoter variant controlling interleukin-6 expression — affects inflammation, exercise recovery, and cardiovascular risk
|
IL6
|
Inflammation & Immune Aging
|
—
|
|
rs688
LDLR
Synonymous LDLR variant that disrupts exon 12 splicing, reduces LDL receptor surface expression by ~22%, and raises LDL cholesterol — particularly in pre-menopausal women
|
LDLR
|
Heart & Cardiovascular
|
—
|
|
rs1801260
CLOCK
Core circadian clock transcription factor variant affecting mRNA stability, associated with evening preference, delayed sleep onset, and shorter sleep duration
|
CLOCK
|
Hormones & Circadian Rhythm
|
—
|
|
rs2229765
IGF1R
Synonymous IGF1R variant associated with lower circulating IGF-1 levels and enrichment in long-lived populations — affects mRNA splicing despite preserving the amino acid sequence
|
IGF1R
|
Metabolism & Blood Sugar
|
—
|
|
rs5186
AGTR1
3' UTR variant in angiotensin II type 1 receptor affecting blood pressure regulation and ARB drug response
|
AGTR1
|
Heart & Cardiovascular
|
—
|
|
rs2295080
MTOR
Promoter variant that reduces mTOR expression; the G allele lowers mTOR transcriptional activity and is associated with decreased cancer risk across multiple tumor types
|
MTOR
|
Metabolism & Blood Sugar
|
—
|
|
rs1695
GSTP1
Phase II detoxification enzyme that conjugates glutathione to carcinogens, drugs, and oxidative stress products; this variant alters the active site geometry, changing substrate specificity
|
GSTP1
|
Methylation & Antioxidants
|
—
|
|
rs1801282
PPARG
Insulin sensitivity - affects how well your cells respond to insulin
|
PPARG
|
Metabolism & Blood Sugar
|
—
|
|
rs2542052
APOC3
Promoter variant that reduces APOC3 expression, associated with lower triglycerides, favorable lipoprotein profiles, and enrichment in centenarians
|
APOC3
|
Heart & Cardiovascular
|
—
|
|
rs17649553
MAPT
Haplotype-tagging variant distinguishing MAPT H1 and H2 clades, affecting risk for Parkinson disease, progressive supranuclear palsy, and other tauopathies
|
MAPT
|
Brain & Cognition
|
—
|
|
rs1799983
NOS3
Nitric oxide production - reduced activity increases cardiovascular risk and oxidative stress
|
NOS3
|
Heart & Cardiovascular, Methylation & Antioxidants
|
—
|
|
rs2736100
TERT
Common intron 2 variant in the telomerase gene that influences telomere length, with the C allele associated with longer telomeres and increased cancer risk, while the A allele links to shorter telomeres and higher risk of degenerative diseases
|
TERT
|
Biological Aging & Telomeres
|
—
|
|
rs1800566
NQO1
Phase II detoxification enzyme that reduces quinones and recycles CoQ10 to its active ubiquinol form; variant causes near-complete loss of enzyme activity
|
NQO1
|
Biological Aging & Telomeres
|
—
|
|
rs2234693
ESR1
Estrogen receptor alpha intron variant affecting receptor expression and estrogen sensitivity
|
ESR1
|
Hormones & Circadian Rhythm
|
—
|
|
rs225014
DIO2
Affects conversion of inactive T4 to active T3 thyroid hormone in brain, pituitary, and peripheral tissues
|
DIO2
|
Hormones & Circadian Rhythm
|
—
|
|
rs429358
APOE
Lipid metabolism and Alzheimer's risk - E4 carriers respond worse to high saturated fat
|
APOE
|
Brain & Cognition
|
—
|
|
rs1801131
MTHFR
Second MTHFR variant affecting enzyme activity in the regulatory domain
|
MTHFR
|
Methylation & Antioxidants
|
—
|
|
rs2802292
FOXO3
Longevity-associated intronic enhancer variant with 1.9-fold increased probability of reaching age 95
|
FOXO3
|
Biological Aging & Telomeres
|
—
|
|
rs4986790
TLR4
Missense variant in Toll-like receptor 4 reducing bacterial endotoxin recognition and dampening inflammatory responses
|
TLR4
|
Inflammation & Immune Aging
|
—
|
|
rs1801133
MTHFR
Key enzyme for converting folate to its active methylfolate form
|
MTHFR
|
Methylation & Antioxidants
|
—
|
|
rs228697
PER3
Core clock gene variant that shifts circadian period length and influences morning vs evening chronotype
|
PER3
|
Hormones & Circadian Rhythm
|
—
|
|
rs662
PON1
Affects paraoxonase-1 enzyme activity for detoxifying organophosphates and protecting LDL from oxidation
|
PON1
|
Heart & Cardiovascular
|
—
|
|
rs2854116
APOC3
APOC3 promoter variant that disrupts insulin suppression of ApoC-III, raising plasma triglycerides and NAFLD risk
|
APOC3
|
Heart & Cardiovascular
|
—
|
|
rs3736228
LRP5
Wnt signaling co-receptor variant affecting bone mineral density and fracture risk
|
LRP5
|
Skeletal & Joints
|
—
|
|
rs1801394
MTRR
B12 recycling enzyme — regenerates active B12 for the methylation cycle
|
MTRR
|
Methylation & Antioxidants
|
—
|
|
rs2304672
PER2
Regulatory variant in a core clock gene that influences circadian timing, sleep-wake preference, and reward processing
|
PER2
|
Hormones & Circadian Rhythm
|
—
|
|
rs350845
SIRT6
Intronic eQTL in SIRT6 where the rare A allele upregulates SIRT6 expression across 18 tissue types and is enriched in Ashkenazi Jewish centenarians, linking higher SIRT6 activity to improved genomic stability and longevity
|
SIRT6
|
Biological Aging & Telomeres
|
—
|
|
rs1805087
MTR
Methionine synthase — uses B12 to convert homocysteine to methionine
|
MTR
|
Methylation & Antioxidants
|
—
|
|
rs3758391
SIRT1
Promoter-region variant in SIRT1 affecting deacetylase expression; T allele elevates SIRT1 levels and is associated with better cognition but increased metabolic and cancer risk; C allele is the common protective form
|
SIRT1
|
Biological Aging & Telomeres
|
—
|
|
rs7412
APOE
APOE E2 variant - generally protective for cardiovascular health
|
APOE
|
Brain & Cognition
|
—
|
|
rs9939609
FTO
The most strongly replicated obesity-associated variant, affecting body weight through reduced adipocyte thermogenesis
|
FTO
|
Metabolism & Blood Sugar
|
—
|
|
rs659366
UCP2
Promoter variant at position -866 of UCP2 that controls mitochondrial uncoupling protein expression; the T allele (A in coding-strand notation) increases UCP2 transcription, lowering ROS production and reducing insulin resistance, while C-allele homozygotes have lower UCP2 activity and carry higher oxidative-stress burden
|
UCP2
|
Metabolism & Blood Sugar
|
—
|
|
rs9594759
TNFSF11
Regulatory variant in the RANKL gene affecting bone mineral density and osteoporotic fracture risk
|
TNFSF11
|
Skeletal & Joints
|
—
|
|
rs6721961
NFE2L2
Promoter variant reducing NRF2 transcriptional activity by >50%, impairing the master antioxidant response that controls glutathione synthesis, phase II detoxification, and cytoprotective gene expression
|
NFE2L2
|
Methylation & Antioxidants
|
—
|
|
rs234706
CBS
Common synonymous variant in the CBS gene associated with reduced cardiovascular disease risk and enhanced response to folate supplementation
|
CBS
|
Methylation & Antioxidants
|
—
|
|
rs4446909
ASMT
Final enzyme in melatonin synthesis; promoter variant reduces ASMT expression and lowers melatonin production, affecting sleep onset and circadian rhythm
|
ASMT
|
Hormones & Circadian Rhythm
|
—
|
|
rs7895833
SIRT1
Intronic variant in SIRT1 affecting NAD-dependent deacetylase expression and oxidative stress protection
|
SIRT1
|
Biological Aging & Telomeres
|
—
|
|
rs9536314
KLOTHO
Longevity-associated variant exhibiting overdominance where heterozygotes show enhanced cognition and lifespan while homozygotes have reduced survival
|
KLOTHO
|
Biological Aging & Telomeres
|
—
|
|
rs356182
SNCA
Parkinson's disease GWAS risk variant affecting alpha-synuclein expression and neuronal differentiation
|
SNCA
|
Brain & Cognition
|
—
|
|
rs4680
COMT
Dopamine/catecholamine breakdown — affects stress response and methyl donor tolerance
|
COMT
|
Methylation & Antioxidants
|
—
|
|
rs3851179
PICALM
Variant in the PICALM gene affecting amyloid-beta clearance across the blood-brain barrier and Alzheimer's disease risk
|
PICALM
|
Brain & Cognition
|
—
|
|
rs700518
CYP19A1
Synonymous variant in aromatase gene affecting estrogen production, bone density, and response to aromatase inhibitors
|
CYP19A1
|
Hormones & Circadian Rhythm
|
—
|
|
rs4880
SOD2
Primary mitochondrial antioxidant enzyme - variant reduces superoxide detoxification in mitochondria
|
SOD2
|
Biological Aging & Telomeres
|
—
|
|
rs6265
BDNF
Key neurotrophin variant that controls activity-dependent BDNF release, affecting memory consolidation, neuroplasticity, and stress resilience
|
BDNF
|
Brain & Cognition
|
—
|
|
rs7903146
TCF7L2
Main type 2 diabetes risk variant - strongly modulated by dietary fat
|
TCF7L2
|
Metabolism & Blood Sugar
|
—
|
|
rs744373
BIN1
Second strongest genetic risk factor for Alzheimer's disease after APOE, associated with increased tau pathology and accelerated cognitive decline
|
BIN1
|
Brain & Cognition
|
—
|
|
rs75932628
TREM2
Rare missense variant in microglial receptor TREM2 that significantly increases late-onset Alzheimer's disease risk through impaired microglial function and amyloid clearance
|
TREM2
|
Brain & Cognition
|
—
|